The T cell response against fungal infections

Current Opinion in Immunology

Volumn 9, Issue 4, 1997, Pages 484-490

  Romani, Luigina ^a  

^a Microbiology Section   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR IMMUNITY; HELPER CELL; HOST SUSCEPTIBILITY; INFECTION SENSITIVITY; MYCOSIS; PATHOLOGY; REVIEW; T LYMPHOCYTE;

EID: 0030765778     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(97)80099-4     Document Type: Article

References (85)

1. Romani L, Howard DH. Mechanisms of resistance to fungal infections. Curr Opin Immunol. 7:1995;517-523.
2. Murphy JW, Friedman H, Bendinelli M. Fungal Infections and Immune Responses. 1993;Plenum Press, New York.
3. Murphy JW, Bistoni F, Deepe GS Jr, Blackstock RA, Buchanan K, Ashman RB, Romani L, Mencacci A, Cenci E, FèD'Ostiani C, et al. Type 1 and type 2 cytokines: from basic science to fungal infections. of special interest J Med Vet Mycol. 1997; See annotation [73].
4. Magee DM, Cox RA. Roles of gamma interferon and interleukin-4 gn genetically determined resistance to Coccidioides immitis. Infect Immun. 63:1995;3514-3519.
5. Magee DM, Cox RA. Interleukin-12 regulation of host defenses against Coccidioides immitis. Infect Immun. 64:1996;3609-3613.
6. Cano LE, Singer-Vermes LM, Vaz CCA, Russo M, Calich VLG. Pulmonary paracoccidioidomycosis in resistant and susceptible mice: relationship among progression of infection, bronchoalveolar cell activation, cellular immune responses and specific isotype patterns. Infect Immun. 63:1995;1777-1783.
7. Zhou P, Sieve MC, Bennett J, Kwon-Chung KJ, Tewari RP, Gazzinelli RT, Sher A, Seder RA. IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-γ J Immunol. 155:1995;785-795.
8. Seder RA, Kelsall BL, Jankovic D. Differential roles for IL-12 in the maintenance of immune responses in infectious versus autoimmune disease. J Immunol. 157:1996;2745-2748.
9. Zhou P, Sieve MC, Tewari RP, Seder RA. Interleukin-12 modulates the protective immune response in SCID mice infected with Histoplasma capsulatum. of special interest Infect Immun. 65:1997;936-942 Provides evidence that, in the absence of a functional T cell compartment, the innate immune system may successfully cope with fungi, provided IL-12 has been administered. See also annotation [85].
10. Hoag KA, Street NE, Huffnagle GB, Lipscomb MF. Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice. Am J Respir Cell Mol Biol. 13:1995;487-495.
11. Nagai H, Guo I, Choi H, Kurup VP. Interferon-γ and tumor necrosis factor-α protect mice from invasive aspergillosis. J Infect Dis. 172:1995;1554-1560.
12. Cenci E, Perito S, Enssle K-H, Mosci P, Latgé JP, Romani L, Bistoni F. Th1 and Th2 cytokines in mice with invasive aspergillosis. Infect Immun. 65:1997;564-570.
13. Romani L, Puccetti P, Bistoni F. Biological role of Th cell subsets in candidiasis. of special interest Chem Immunol. 63:1996;115-137 A comprehensive review of the evidence and implications of the Th cell dichotomy in candidal infections and Candida-related pathology.
14. Fidel PL Jr, Lynch ME, Conaway DH, Tait L, Sobel JD. Mice immunized by primary vaginal Candida albicans infection develop vaginal mucosal immunity. Infect Immun. 63:1995;547-553.
15. + T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J Exp Med. 183:1996;1345-1355.
16. Jensen J, Warner T, Johnson C, Balish E. Oral immunization of mice against candidiasis. J Infect Dis. 174:1996;133-140.
17. + T-helper-cell responses in mice with low-level Candida albicans infection. of special interest Infect Immun. 64:1996;4907-4914 This paper shows the dynamics of the development of the Th cell response in mice with a low- to moderate-level of C. albicans infection. Th2 responses are only observed by increasing the fungal load. Induction of Th1 anti-candidal responses occurs in mice with a low level C. albicans infection. The Th1 response, however, does not result in the development of a memory protective response, which correlates instead with antigen persistence in vivo and requires IL-4.
18. Romani L, Puccetti P, Bistoni F. Interleukin-12 in infectious diseases. in press Clin Microbiol Rev. 1997.
19. Hanano R, Reifenberg K, Kaufmann SHE. Naturally acquired Pneumocystis carinil pneumonia in gene disruption mutant mice: roles of distinct T-cell populations in infection. Infect Immun. 64:1996;3201-3209.
20. + lymphocytes in host defense against Pneumocystis carinii in mice. J Lab Clin Med. 128:1996;477-487.
21. Theus SA, Andrews RP, Steele P, Walzer PD. Adoptive transfer of lymphocytes sensitized to the major surface glycoprotein of Pneumocystis carinii confers protection in the rat. J Clin Invest. 95:1995;2587-2593.
22. Garvy BA, Ezekowitz RAB, Harmsen AG. Role of gamma interferon in the host immune and inflammatory responses to Pneumocystis carinii infection. Infect Immun. 65:1997;373-379.
23. Hanano R, Reifenberg K, Kaufmann SHE. Activated pulmonary macrophages are insufficient for resistance against Pneumocystis carinii. in press Infect Immun. 1997.
24. Lilic D, Cant AJ, Abinun M, Calvert JE, Spickett GP. Chronic mucocutaneous candidiasis. I. Altered antigen-stimulated IL-2, IL-4, IL-6 and interferon-gamma (IFN-γ) production. of special interest Clin Exp Immunol. 105:1996;205-212 See annotation [25].
25. Lilic D, Calvert JE, Cant AJ, Abinun M, Spickett GP. Chronic mucocutaneous candidiasis. II. Class and subclass of specific antibody responses in vivo and in vitro. of special interest Clin Exp Immunol. 105:1996;213-219 Together with [24], this is a most important finding showing that a predominantly Th2 response, instead of a Th1 response, occurs in patients with chronic mucocutaneous candidiasis.
26. Harrison TS, Levitz SM. Priming with IFN-γ restores deficient IL-12 production by peripheral blood mononuclear cells from HIV-seropositive donors. J Immunol. 158:1997;459-463.
27. Harrison TS, Levitz SM. Role of IL-12 in peripheral blood mononuclear cell responses to fungi in persons with and without HIV infection. J Immunol. 156:1996;4492-4497.
28. + T-lymphocytes in the cerebrospinal fluid in Coccidioides immitis meningitis. J Med Vet Mycol. 33:1995;43-48.
29. Galgiani JN, Peng T, Lewis ML. Cerebrospinal fluid antibodies detected by ELISA against a 33-kDa antigen from spherules of Coccidioides immitis in patients with coccidioidal meningitis. J Infect Dis. 173:1996;499-502.
30. Corry DB, Ampel NM, Christian L, Locksley RM, Galgiani JN. Cytokine production by peripheral blood mononuclear cells in human coccidioidomycosis. of special interest J Infect Dis. 174:1996;440-443 Clear evidence is provided showing the decreased production of Th1 cytokines, such as IFN-γ and IL-12, in patients with disseminated fungal infection.
31. Munk ME, Kaufmann SHE. Human cord blood T-cell receptor cell responses to protein antigens of Paracoccidioides brasiliensis yeast forms. Immunology. 84:1995;98-104.
32. Wagner DK, Sohnle PG. Cutaneous defenses against dermatophytes and yeasts. Clin Microbiol Rev. 8:1995;317-335.
33. Leibovici V, Evron R, Axelrod O, Westerman M, Shalit M, Barak V, Frankenburg S. Imbalance of immune responses in patients with chronic and widespread fungal skin infection. Clin Exp Dermatol. 20:1995;390-394.
34. Kröger S, Neuber K, Gruseck E, Ring J, Abeck D. Pityrosporum ovale extracts increase interleukin-4, interleukin-10 and IgE synthesis in patients with atopic eczema. Acta Derm Venereol (Stockh). 75:1995;357-360.
35. Lintu P, Savolainen J, Kalimo K. IgE antibodies to protein and mannan antigens of Pityrosporum ovale in atopic dermatitis patients. Clin Exp Allergy. 27:1997;87-95.
36. Woodfolk JA, Slunt JB, Deuell B, Hayden ML, Platts-Mills TAE. Definition of a Trichophyton protein associated with delayed type hypersensitivity in humans: evidence for immediate (IgE and IgG4) and delayed hypersensitivity to a single protein. J Immunol. 156:1996;1695-1701.
37. Slunt JB, Taketomi EA, Woodfolk JA, Hayden ML, Platts-Mills TAE. The immune response to Trichophyton tonsurans. Distinct T cell cytokine profiles to a single protein among subjects with immediate and delayed hypersensitivity. J Immunol. 157:1996;5192-5197.
38. Munk ME, Fazioli RA, Calich VLG, Kaufmann SHE. Paracoccidioides brasiliensis-stimulated γ /δ T cells support antibody production by B cells. Infect Immun. 63:1995;1608-1610.
39. Pahl HL, Krau B, Schulze-Osthoff K, Decker T, Traenckner EB, Vogt M, Myers C, Parks T, Warring P, Mühlbacher A, et al. The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-κB. of special interest J Exp Med. 183:1996;1829-1840 An interesting study showing that inhibition of transcription factor NF-κB may be one possible mechanism through which a fungal metabolite may interfere with host immune responses.
40. Tavares D, Ferreira P, Vilanova M, Videira A, Arala-Chaves M. Immunoprotection against systemic candidiasis in mice. Int Immunol. 7:1995;785-796.
41. Huffnagle GB, Chen G-H, Curtis JL, McDonald RA, Streiter RM, Toews GB. Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans. J Immunol. 155:1995;3507-3516.
42. Chauhan B, Knutsen AP, Hutcheson PS, Slavin RG, Bellone CJ. T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis. J Clin Invest. 97:1996;2324-2331.
43. Grünig G, Corry DB, Leach MW, Seymour BWP, Kurup VP, Rennick DM. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J Exp Med. 185:1997;1089-1100.
44. Crameri R, Faith A, Hemmann S, Jaussi R, Ismail C, Menz G, Blaser K. Humoral and cell-mediated autoimmunity in allergy to Aspergillus fumigatus. of special interest J Exp Med. 184:1996;265-270 This study presents clear evidence of the occurrence of autoimmune responses to cross-reactive self antigens in the course of a fungal disease.
45. Ashman RB, Papadimitriou JM. Production and function of cytokines in natural and acquired immunity to Candida albicans infection. Microbiol Rev. 59:1995;646-672.
46. Levitz SM, North EA. Gamma interferon gene expression and release in human lymphocytes directly activated by Cryptococcus neoformans and Candida albicans. Infect Immun. 64:1996;1595-1599.
47. Walsh P, Norris DA, Abe J, Martin DK, Giorno R, Leung DYM. Candida albicans induces selective expansion of human T lymphocytes expressing the T-cell receptor variable region V5.1. J Dermatol Sci. 12:1996;140-146.
48. Spaccapelo R, Del Sero G, Mosci P, Bistoni F, Romani L. Early T cell unresponsiveness in mice with candidiasis and reversal by IL-2. Effect on T helper cell development. J Immunol. 158:1997;2294-2302.
49. Kozel TR. Activation of the complement system by pathogenic fungi. Clin Microbiol Rev. 9:1996;34-46.
50. Ashman RB, Fulurija A, Papadimitriou JM. Strain-dependent differences in host response to Candida albicans infection in mice are related to organ susceptibility and infectious load. Infect Immun. 64:1996;1866-1869.
51. Morgenstern DE, Gifford MAC, Li LL, Doerschuk CM, Dinauer MC. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus. J Exp Med. 185:1997;207-218.
52. + T cells during a pulmonary Cryptococcus neoformans infection. J Immunol. 155:1995;4790-4797.
53. Huffnagle GB, Toews GB, Burdick MD, Boyd MB, McAllister KS, McDonald RA, Kunkel SL, Streiter RM. Afferent phase production of TNF-α is required for the development of protective T cell immunity to Cryptococcus neoformans. J Immunol. 157:1996;4529-4536.
54. Steinsham S, Bemelmans MHA, van Tits LJH, Bergh K, Buurman WA, Waage A. TNF receptors in murine Candida albicans infection. Evidence for an important role of TNF receptor p55 in antifungal defense. J Immunol. 157:1996;2155-2159.
55. Levitz SM, North EA, Jiang Y, Nong S-H, Kornfeld H, Harrison TS. Variables affecting production of monocyte chemotactic factor 1 from human leukocytes stimulated with Cryptococcus neoformans. Infect Immun. 65:1997;903-908.
56. Yamamoto Y, Klein TW, Freidman H. Involvement of mannose receptor in cytokine interleukin-1β (IL-1β), IL-6, and granulocyte-macrophage colony-stimulating factor responses, but not in chemokine macrophage inflammatory protein 1β (MIP-1), MIP-2, and KC responses, caused by attachment of Candida albicans to macrophages. Infect Immun. 65:1997;1077-1082.
57. Filler SG, Pfunder AS, Spellberg BJ, Spellberg JP, Edwards JE Jr. Candida albicans stimulates cytokine production and leukocyte adhesion molecule expression by endothelial cells. Infect Immun. 64:1996;2609-2617.
58. + T helper selection in mice with candidiasis. J Immunol. 158:1997;2356-2362.
59. Romani L, Mencacci A, Cenci E, Spaccapelo R, Del Sero G, Nicoletti I, Trinchieri G, Bistoni F, Puccetti P. Neutrophil production of IL-12 and IL-10 in candidiasis and efficacy of IL-12 therapy in neutropenic mice. of special interest J Immunol. 158:1997;5349-5356 See annotation [60].
60. Romani L, Bistoni F, Puccetti P. Initiation of T helper cell immunity to Candida albicans by IL-12: the role of neutrophils. of special interest Chem Immunol. 1997; Together with [59], this is the first direct evidence that neutrophils, by the production of directive cytokines such as IL-10 and IL-12, influence Th cell development in mice with disseminated candidiasis and that the immuno-regulatory function of neutrophils can be efficiently restored by replacement therapy with IL-12 in neutropenic mice.
61. Romani L, Mencacci A, Cenci E, Puccetti P, Bistoni F. Neutrophils and the adaptive immune response to Candida albicans. Res Immunol. 147:1997;512-518.
62. Mencacci A, Cenci E, Boelaert JR, Bucci P, Mosci P, FèD'Ostiani C, Bistoni F, Romani L. Iron overload alters innate and T helper cell responses to Candida albicans in mice. J Infect Dis. 175:1997;1467-1476.
63. Wiley JA, Harmsen AG. CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice. J Immunol. 155:1995;3525-3529.
64. Wagner RD, Vazquez-Torres A, Jones-Carson J, Warner T, Balish E. B cell knockout mice are resistant to mucosal and systemic candidiasis of endogenous origin but susceptible to experimental systemic candidiasis. J Infect Dis. 174:1996;589-597.
65. Aguirre KM, Johnson LL. A role for B cells in resistance to Cryptococcus neoformans in mice. Infect Immun. 65:1997;525-530.
66. Marcotte H, Lévesque D, Delanay K, Bourgeault A, de la Durantaye R, Brochu S, Lavoie MC. Pneumocystis carinii infection in transgenic B cell deficient-mice. J Infect Dis. 173:1996;1034-1037.
67. Jones-Carson J, Vazques-Torres FA, Balish E. B cell-independent selection of memory T cells after mucosal immunization with Candida albicans. of special interest J Immunol. 158:1997;4328-4335 This is an important study showing that mucosal, but not parenteral, immunization with C. albicans evokes mucosal and systemic T cell responses.
68. 2-microglobulin in murine resistance to mucosal and systemic candidiasis. Infect Immun. 64:1996;5092-5097.
69. Casadevall A. Antibody immunity and invasive fungal infections. Infect Immun. 63:1995;4211-4218.
70. Nussbaum G, Yuan R, Casadevall A, Scharff MD. Immunoglobulin G3 blocking antibodies to Cryptococcus neoformans. J Exp Med. 183:1996;1905-1909.
71. Nussbaum G, Cleare W, Casadevall A, Scharff MD, Valadon P. Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy. J Exp Med. 185:1997;685-694.
72. Feldmesser M, Casadevall A. Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection. J Immunol. 158:1997;790-799.
73. Casadevall A, Cassone A, Bistoni F, Cutler JE, Magliani W, Murphy JW, Polonelli L, Romani L. Antibody- and/or cell-mediated Immunity-protective mechanisms in fungal disease: an ongoing dilemma or an unnecessary dispute? of special interest J Med Vet Mycol. 1997; Along with [3], this paper offers a comprehensive up-to-date analysis of the relative contribution and the interplay between Th- and antibody-mediated immunity in host defense against fungi.
74. + T cells.
75. Han Y, Cutler JE. Assessment of a mouse model of neutropenia and the effect of an anti-Candida monocional antibody in these animals. J Infect Dis. 175:1997;1169-1175.
76. Polonelli L, De Bernardis F, Connate S, Boccanera M, Magliani W, Gerloni M, Cantelli C, Cassone A. Human natural yeast killer toxin-like candidacidal antibodies. of special interest J Immunol. 156:1996;1880-1885 This study shows the occurrence of candidacidal antibodies functionally mimicking the activity of a killer toxin in the vaginal fluids of patients with vaginitis and infected with Candida. The implications of this finding may be twofold: at the conceptual and therapeutic levels.
77. Matthews R, Burnie J. Antibodies against Candida: potential therapeutics? Trends Microbiol. 4:1996;354-358.
78. Cassone A, Conti S, De Bernardis F, Polonelli L. Antibodies, killer toxins and antifungal immunoprotection: a lesson from nature. of special interest Immunol Today. 18:1997;164-169 A timely viewpoint on the interplay between natural antibody and cellular immunity to fungi with possible important implications for immunotherapy of fungal infections.
79. Roilides E, Dimitriadou A, Kadiltsoglou I, Sein T, Karpouzas, Pizzo PA, Walsh TJ. IL-10 exerts suppressive and enhancing effects on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J Immunol. 158:1997;322-329.
80. Levitz SM, Tabuni A, Nong S-H, Golenbock DT. Effects of interleukin-10 on human peripheral blood mononuclear cell responses to Cryptococcus neoformans, Candida albicans, and lipopolysaccharide. Infect Immun. 64:1996;945-951.
81. Vecchiarelli A, Retini C, Monari C, Tascini C, Bistoni F, Kozel TR. Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes. Infect Immun. 64:1996;2846-2849.
82. Levitz SM, Mathews HL, Murphy JW. Direct antimicrobial activity of T cells. Immunol Today. 16:1995;387-391.
83. + lymphocytes. J Immunol. 154:1995;5273-5281.
84. Deepe GS, Gibbons R, Brunner GD, Gomez FJ. A protective domain of heat shock protein 60 from Histoplasma capsulatum. J Infect Dis. 174:1996;828-834.
85. Cenci E, Mencacci A, Del Sero G, Bistoni F, Romani L. Induction of protective Th1 responses to Candida albicans by antifungal therapy alone or in combination with an interleukin-4 antagonist. of special interest J Infect Dis. 176:1997;217-226 Together with [9], this study demonstrates the synergism between antifungal chemotherapy and IL-12 or an IL-4 antagonist in experimental fungal infections of immunocompetent and immunoincompetent mice.